ISMRM22 - Hot Topics in Body MRI: MRI of Gender Imaging

Joint Annual Meeting ISMRM-ESMRMB & ISMRT 31st Annual Meeting • 07-12 May 2022 • London, UK

Hot Topics in Body MRI: MRI of Gender Imaging

Sunrise Course

ORGANIZERS: Masako Kataoka, Nandita DeSouza, Jurgen Fütterer, Hero Hussain, Katja Pinker-Domenig, Scott Reeder, Jeffrey Maki

Wednesday, 11 May 2022

ICC Capital Suite 10-11

08:00 - 09:00

Moderators: Aki Kido

Skill Level: Basic to Advanced

Session Number: S-W-03

Session Number: S-W-03

Overview
The series of talks covers hot topics in body MRI. The topics include:

1) MRI of gender imaging (prostate & female pelvis): Two specific areas of gender imaging that may be exploited in the clinic will be addressed--multiparametric MRI in metastatic ovarian cancer and low field MRI for prostate cancer screening.

2) MRI of the pancreas: From basic anatomy / protocols to more advanced techniques will be covered to highlight this hidden organ.

3) Multi-organ, COVID-19-related, vaccine-associated conditions on MRI: With wide-use of COVID-19 vaccination, reactive adenopathy and other vaccine-related reactions are completely new conditions that clinicians must know. The two talks cover the latest evidence and recommendations. Images of COVID-19-related multi-organ conditions are also covered.

4) MRI for moving organs (motility imaging): A unique opportunity reviewing technical aspect and interpretation skills required for MRI of moving organs.

Target Audience
Basic to advanced, both clinicians and Ph.D.s interested in body MRI.

Educational Objectives
As a result of attending this course, participants should be able to:
- Describe the utility of multiparametric MRI over CT for assessing metastatic ovarian cancer;
- Recognize what is needed to make prostate cancer screening viable with low field MRI;
- Describe the requirements for basic and advanced imaging of the pancreas;
- Recognize the imaging features of multi-organ COVID-19-related or vaccine-associated pathology; and
- Describe the techniques required for MRI of moving organs and interpret their imaging appearances.

	08:00		Evaluating Metastatic Ovarian Malignancy: Does MRI Provide Gains over CT? View the Presentation Anju Sahdev A woman’s lifetime risk of developing invasive ovarian cancer is 1 in 79 and most present with metastatic disease and continue to have a poor outcome. Metastatic disease, in present standard practice, is detected and surgically mapped by CT of the chest, abdomen and pelvis. On a lesion-by-lesion basis MRI with DWI and with post gadolinium enhancement detects more lesions than CT. However, overall MRI has a limited role for staging at primary presentation and overall offers only limited superiority over CT. For primary and recurrent disease, MRI’s role in pelvic disease detection and surgical planning is superior to CT.
	08:30		What Will Bring Low-Field MRI to Prostate Cancer Screening? View the Presentation Masoom Haider Low field MRI has the potential to aid in wider global utilization of MRI for prostate cancer diagnosis through cost reduction and easier installation and lower service costs. If optimized it also can help improve image quality for example, through reduced susceptibility. Patients with pacemakers may be able to undergo DWI more easily. MRI guided biopsy and intervention may also benefit from improved siting and less demands on hardware Further work in optimal hardware engineering and image pipeline optimization is needed.